ReviewTherapeutic advances in medical oncology2025
Current status of radionuclide therapies in metastatic castration-resistant prostate cancer.
Xin Fei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it